Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2012 Carcinoma, Non-Small-Cell Lung 1228 Breast Neoplasms 1215 Leukemia, Myeloid, Acute 967 Neoplasm Metastasis 902 Melanoma 778 Colorectal Neoplasms 752 Multiple Myeloma 725 Lymphoma 725 Ovarian Neoplasms 675 Pancreatic Neoplasms 665 Lymphoma, Non-Hodgkin 659 Prostatic Neoplasms 657 Recurrence 637 Precursor Cell Lymphoblastic Leukemia-Lymphoma 585 Lung Neoplasms 560 Leukemia, Lymphocytic, Chronic, B-Cell 555 Glioblastoma 527 Leukemia 486 Lymphoma, Large B-Cell, Diffuse 440 Lymphoma, Follicular 419 Brain Neoplasms 415 Squamous Cell Carcinoma of Head and Neck 389 Stomach Neoplasms 387 Carcinoma, Renal Cell 385 Myelodysplastic Syndromes 382 Carcinoma, Hepatocellular 368 Advanced Solid Tumors 357 Lymphoma, Mantle-Cell 345 Glioma 343

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Locally-advanced Rectal Cancer × Clear all

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡